| scholarly article | Q13442814 |
| P2093 | author name string | Yang Wang | |
| Yue Yang | |||
| Ping Li | |||
| Xiang-Mei Chen | |||
| Meng-Jie Huang | |||
| Ri-Bao Wei | |||
| Ting-Yu Su | |||
| P2860 | cites work | Insulin resistance in patients with chronic kidney disease | Q21285003 |
| Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies | Q24632655 | ||
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity | Q33834971 | ||
| A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients | Q34992325 | ||
| Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cells | Q35641692 | ||
| Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism | Q35820304 | ||
| The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 | ||
| Signaling crosstalk angiotensin II receptor subtypes and insulin | Q36423729 | ||
| Measurement of insulin resistance in chronic kidney disease | Q37017696 | ||
| The Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle. | Q37039767 | ||
| Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk | Q37374133 | ||
| The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men | Q39513420 | ||
| Diverticulum of the lacrimal sac. | Q39828536 | ||
| Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. | Q40230599 | ||
| Complement-mediated immune mechanisms in renal infection. II. Effect of decomplementation | Q40954241 | ||
| Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors | Q41385804 | ||
| Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats | Q42380235 | ||
| An enzymatic photometric assay for 2-deoxyglucose uptake in insulin-responsive tissues and 3T3-L1 adipocytes | Q42815574 | ||
| Clinical epidemiology of cardiovascular disease in chronic renal disease | Q43631482 | ||
| Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease | Q44044865 | ||
| Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling | Q44240408 | ||
| The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study | Q44425360 | ||
| Higher HOMA-IR index and correlated factors of insulin resistance in patients with IgA nephropathy | Q44676820 | ||
| Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey | Q44693873 | ||
| Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice | Q44810052 | ||
| Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells | Q44814457 | ||
| Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. | Q46414907 | ||
| Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients | Q46870675 | ||
| Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients. | Q51471397 | ||
| Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome. | Q52670596 | ||
| Fatal ingestion of tintacks by chimpanzee. | Q52854609 | ||
| Insulin action in uremia. | Q54486853 | ||
| Chronic Lead Poisoning Occurring in the Manufacture of Steel | Q58748901 | ||
| Legality of research on children | Q66700844 | ||
| Experimental uremia. Description of a model producing varying degrees of stable uremia | Q71339049 | ||
| Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade | Q77795070 | ||
| The value of a health service to the insurance company | Q79319672 | ||
| Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH) | Q85353098 | ||
| P921 | main subject | insulin resistance | Q1053470 |
| P304 | page(s) | 2413-2419 | |
| P577 | publication date | 2018-04-21 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Valsartan Alleviates Insulin Resistance in Skeletal Muscle of Chronic Renal Failure Rats | |
| P478 | volume | 24 |
Search more.